Withings BeamO launches in the US with FDA clearance
Withings has received FDA clearance for BeamO in the US and is launching it nationwide on November 13. This follows its earlier European rollout and brings the multiscope device into homes for family health tracking and telehealth support.
BeamO now available in the United States
The BeamO is not new. Withings originally announced it back at CES 2024 and started selling it in Europe about a year later. But now it’s finally cleared for use in the US, following FDA approval. That opens the door for wider adoption among American households looking for more than just a thermometer or pulse oximeter.
At its core, BeamO combines four measurements in one compact unit. It takes your temperature without contact, checks blood oxygen, records a single-lead ECG, and lets you listen to heart and lung sounds using a built-in digital stethoscope. It’s meant to replace multiple home health tools with a single device that can handle more complex assessments, especially during virtual doctor visits.
What’s different about the US launch
There’s no major hardware change for the US market, but the key development is regulatory. Withings has now secured FDA clearance, which is a prerequisite for medical claims and wide distribution in the States. The device is available directly from Withings for $249.95.
The company is also leaning heavily into BeamO’s telehealth applications. One feature is called HealthLink, which lets users generate a web link to share their health data live with clinicians. Audio from the stethoscope can be heard in real time during video consultations, and ECG data is viewable remotely. The readings are stored in the Withings app and can be exported as full PDF reports.
Targeting families and check-in culture
The design clearly aims at family health monitoring. Withings wants BeamO to be the device you grab when your kid spikes a fever or when a parent starts coughing and you’re not sure if it’s serious. The stethoscope lets you listen for crackling or wheezing, and the ECG might help spot irregular heartbeats that you’d otherwise miss.
All of this assumes people know how to use the device properly. That’s still a challenge for at-home clinical tools. If the stethoscope isn’t placed correctly, for example, the data won’t be reliable. And the ECG, while useful for spotting arrhythmias, isn’t a substitute for multi-lead clinical equipment.
Where it fits
BeamO doesn’t do 24/7 tracking. Instead, it’s more like a connected check-up tool you keep on a shelf and bring out when needed. It complements wearables rather than replacing them.
The pricing positions it in the mid-premium range, and there’s some crossover with Withings’ existing ecosystem if you’re already using their scales or hybrid watches. Over time, it’ll be worth seeing whether families treat BeamO as a regular part of their routines or just something for occasional use.
Subscribe to our monthly newsletter! Check out our YouTube channel.
And of course, you can follow Gadgets & Wearables on Google News and add us as a preferred source to get our expert news, reviews, and opinion in your feeds.
